ConductScience.org, home

Gene · 2197

FAU: FAU ubiquitin like and ribosomal protein S30 fusion

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. FAU: FAU ubiquitin like and ribosomal protein S30 fusion. Genes, record 2197. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2197

On this page

Gene

Symbol
FAU
HGNC
Name
FAU ubiquitin like and ribosomal protein S30 fusion
HGNC
NCBI Gene ID
2197
NCBI Gene
HGNC ID
HGNC:3597
HGNC
Ensembl
ENSG00000149806
NCBI Gene
Aliases
FAU1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30, asr1, eS30
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P62861Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein133195Ensembl, GeneID, HGNC

Source UniProt

Patents33

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1446367P62861Espacenet
JP 2026004568 A2026-01-1446369P62861Espacenet
JP 2026004568 A2026-01-1446370P62861Espacenet
EP 4650780 A22025-11-1915458P62861Espacenet
EP 4641202 A22025-10-297575P62861Espacenet
JP 2025517970 A2025-06-1215458P62861Espacenet
KR 1020250017231 A2025-02-047575P62861Espacenet
US 11446398 B22022-09-2032175P62861Espacenet
US 11446398 B22022-09-2032177P62861Espacenet
US 11446398 B22022-09-2032179P62861Espacenet

1 to 10 of 33

See all 33 patents

Drugs9

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ATALURENCHEMBL25699780S Ribosome modulatorMODULATORChEMBL
CITATUZUMAB BOGATOXCHEMBL174300080S Ribosome inhibitorINHIBITORChEMBL
CYCLOHEXIMIDECHEMBL12329280S Ribosome inhibitorINHIBITORChEMBL
DORLIMOMAB ARITOXCHEMBL210912480S Ribosome inhibitorINHIBITORChEMBL
ELX-02CHEMBL429774480S Ribosome modulatorMODULATORChEMBL
MT-3724CHEMBL429778980S Ribosome inhibitorINHIBITORChEMBL
TAPLITUMOMAB PAPTOXCHEMBL210789080S Ribosome inhibitorINHIBITORChEMBL
TELIMOMAB ARITOXCHEMBL210879080S Ribosome inhibitorINHIBITORChEMBL
ZOLIMOMAB ARITOXCHEMBL210878580S Ribosome inhibitorINHIBITORChEMBL

Trials38

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07523581ELX-02PHASE2ClinicalTrials.gov
NCT05448755ELX-02PHASE22026-02-24ClinicalTrials.gov
NCT04336826ATALURENPHASE22024-04-01ClinicalTrials.gov
NCT04135495ELX-02PHASE2ClinicalTrials.gov
NCT04126473ELX-02PHASE2ClinicalTrials.gov
NCT04117880ATALURENPHASE2ClinicalTrials.gov
NCT04069260ELX-02PHASE2ClinicalTrials.gov
NCT04014530ATALURENPHASE1/PHASE2ClinicalTrials.gov
NCT03796637ATALURENPHASE22022-04-05ClinicalTrials.gov
NCT03645395MT-3724PHASE22022-08-16ClinicalTrials.gov

1 to 10 of 38

See all 38 trials

NIH grants446

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFAU papersNewest fiscal year
P30CA016086Cancer Center Support Grant32025
P30CA022453CANCER CENTER SUPPORT GRANT32025
P01CA092584Structural Cell Biology of DNA Repair Machines22025
P30CA014195Cancer Center Support Grant (CCSG)22025
R01GM144367Structural and Functional Analysis of Proteasome Core Particle Biogenesis22025
P01HL131478Stress-induced immune reprogramming in cardiovascular disease12025
P20GM103418Kansas IDeA Network of Biomedical Research Excellence 512025
P20GM103476Mississippi INBRE12025
P20GM113132The Institute for Biomolecular Targeting12025
P20GM121176Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.12025

1 to 10 of 446Source NIH's project files

See all 446 nih grants

Papers734

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
[Mining of ancestral lipases and enzymatic synthesis of amides].Sheng Wu Gong Cheng Xue Bao202642343804PubTator, text miningPubMed
Integrative Transcriptomic, Network, and Genomic Analysis of Peripheral Blood Mononuclear Cells Identifies Candidate Genes Associated with Dupilumab Clinical Response in Atopic Dermatitis Patients.Int J Mol Sci202642278672PubTator, text miningPubMed
Lipocentric Non-Pore-Forming Membrane Depolarization Underlies the Antibacterial Activity of Ribosomal Protein S30.J Phys Chem Lett202641943536PubTator, text miningPubMed
Biosynthesis of zinc oxide and silver/zinc oxide nanocompositesusing Kalanchoe pinnata leaf extracts for antibacterial and anticancer applications.Discov Nano202641931199PubTator, text miningPubMed
Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term.EBioMedicine202641849830PubTator, text miningPubMed
Synthetic Strategies for Activity-Based Probes to Decode Ubiquitin-Like Modifiers.Chemistry202641728666PubTator, text miningPubMed
From Covalent Traps to Fluorescent Beacons: The Expanding Arsenal of Chemical Probes for Studying Ubiquitin and Ubiquitin-Like Proteins.Angew Chem Int Ed Engl202641673774PubTator, text miningPubMed
Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma.J Immunother Cancer202641617396PubTator, text miningPubMed
Combining Mesoporosity and Shape Selectivity in FAU-MFI Interzeolite Intermediates for Renewable Xylenes Production.ACS Sustain Chem Eng202641541633PubTator, text miningPubMed
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.J Transl Med202641527127PubTator, text miningPubMed

1 to 10 of 734

See all 734 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2197

GET https://conductscience.org/api/genes/v1/2197/patents?page=2